Osivax, a biopharmaceutical company developing vaccines to provide broad-spectrum protection against highly mutating infectious viruses, today announced that the first participant has been vaccinated ...

Italfarmaco has entered into an agreement with Multicare for the regulatory approval and distribution of givinostat as a treatment for Duchenne muscular dystrophy in Brazil.

Cantoni was founded in December 2022 as a spinout from Leiden University by scientific founders Professor Nathaniel Martin and Dr. Matthijs van Haren, scientists with an impressive track-record in ...

The 2025 Imprivata State of Shared Mobile Devices in Healthcare Report reveals both opportunity and challenges for UK healthcare organisations to better leverage shared-use mobile devices in the ...

EDINBURGH, Scotland, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Cumulus Oncology, an oncology and inflammation focused biotech, announces the expansion of its Board of Directors (BoD) and scientific advisory ...

We are very pleased with the continued funding under the OTA with BARDA to support the development of our antifungal drug candidates fosmanogepix and BAL2062. These compounds, with novel mechanisms of ...

Leading with the gold-standard Registered in Musculoskeletal ® Sonography Certification (RMSK ®) certification, the new sites will support clear, simple accreditation across specialties—empowering ...

Bright Green Corporation (OTC: BGXX) has announced its merger with PharmAGRI Capital Partners, a federally aligned pharmaceutical infrastructure platform architected to restore U.S. drug manufacturing ...

Around two-thirds (64%) of respondents reported that their mental health improved since starting Wegovy ® treatment. 1 Substantial majorities also reported developing a healthier lifestyle (76%) and ...

TORONTO, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX:VHI) (OTCQX:VHIBF) (the "Company" or "VitalHub") announced today that it has changed its auditor from MNP LLP (the “Former Auditor”) to ...

H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.

Parexel, a leading global clinical research organization (CRO), and Paradigm Health, a company rebuilding the clinical research ecosystem, today announced a strategic partnership to evolve how ...